Skip to main content
Erschienen in: Heart Failure Reviews 6/2022

20.07.2022

Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging

verfasst von: Georgios M. Alexandridis, Efstathios D. Pagourelias, Nikolaos Fragakis, Maria Kyriazi, Efthymia Vargiami, Dimitrios Zafeiriou, Vassilios P. Vassilikos

Erschienen in: Heart Failure Reviews | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Neuromuscular diseases (NMDs) include a broad spectrum of disorders that affect motor unit in every possible site, extending from the cell body of peripheral nerves to the muscle. The different lesion sites make this group of inherited disorders difficult to diagnose. Many NMDs, especially those involving skeletal muscles, can present significant cardiovascular complications, ranging from rhythm disturbances to the development of dilated or hypertrophic cardiomyopathy. Heart disease represents a major cause of morbidity and mortality among NMD patients, underlining the vital need for further familiarization with the pathogenesis and assessment of cardiac involvement. Cardiovascular imaging is the cornerstone for the evaluation of heart disorders in NMDs, with conventional echocardiography still offering a portable, affordable, and easily accessible solution. Meanwhile, newer echocardiographic techniques such as speckle tracking imaging in combination with cardiac magnetic resonance add new insights into further substrate characterization. The purpose of this review is to offer a brief presentation of the main NMDs and their cardiovascular complications, as well as the presentation of data that highlight the importance of cardiovascular imaging in early diagnosis, monitoring, and prognosis of these patients. Lastly, the authors provide a simple guide about which clinical features, imaging findings, and follow-up plan to adopt in each myopathic disorder.
Literatur
2.
Zurück zum Zitat Korinthenberg R (2017) Neuromuscular disorders in children and adolescents. Neuropediatrics 48(4):209–210PubMedCrossRef Korinthenberg R (2017) Neuromuscular disorders in children and adolescents. Neuropediatrics 48(4):209–210PubMedCrossRef
3.
Zurück zum Zitat Askanas V, King Engel W (2015) Update on neuromuscular diseases: pathology and molecular pathogenesis. Biochim Biophys Acta 1852(4):561–562PubMedCrossRef Askanas V, King Engel W (2015) Update on neuromuscular diseases: pathology and molecular pathogenesis. Biochim Biophys Acta 1852(4):561–562PubMedCrossRef
4.
Zurück zum Zitat Sáez A, Acha B, Montero-Sánchez A, Rivas E, Escudero LM, Serrano C (2013) Neuromuscular disease classification system. J Biomed Opt 18(6):066017PubMedCrossRef Sáez A, Acha B, Montero-Sánchez A, Rivas E, Escudero LM, Serrano C (2013) Neuromuscular disease classification system. J Biomed Opt 18(6):066017PubMedCrossRef
5.
Zurück zum Zitat Ismail H, Raynor E, Zimetbaum P (2017) Neuromuscular disorders and the role of the clinical electrophysiologist. JACC Clin Electrophysiol 3(10):1069–1079PubMedCrossRef Ismail H, Raynor E, Zimetbaum P (2017) Neuromuscular disorders and the role of the clinical electrophysiologist. JACC Clin Electrophysiol 3(10):1069–1079PubMedCrossRef
6.
Zurück zum Zitat Feingold B, Mahle WT, Auerbach S, Clemens P, Domenighetti AA, Jefferies JL, Judge DP, Lal AK, Markham LW, Parks WJ, Tsuda T, Wang PJ, Yoo SJ (2017) Management of cardiac involvement associated with neuromuscular diseases: a scientific statement from the american heart association. Circulation 136(13):e200–e231PubMedCrossRef Feingold B, Mahle WT, Auerbach S, Clemens P, Domenighetti AA, Jefferies JL, Judge DP, Lal AK, Markham LW, Parks WJ, Tsuda T, Wang PJ, Yoo SJ (2017) Management of cardiac involvement associated with neuromuscular diseases: a scientific statement from the american heart association. Circulation 136(13):e200–e231PubMedCrossRef
7.
Zurück zum Zitat Arbustini E, Di Toro A, Giuliani L, Favalli V, Narula N, Grasso M (2018) Cardiac phenotypes in hereditary muscle disorders: JACC state-of-the-art review. J Am Coll Cardiol 72(20):2485–2506PubMedCrossRef Arbustini E, Di Toro A, Giuliani L, Favalli V, Narula N, Grasso M (2018) Cardiac phenotypes in hereditary muscle disorders: JACC state-of-the-art review. J Am Coll Cardiol 72(20):2485–2506PubMedCrossRef
8.
Zurück zum Zitat Limpitikul W, Ong CS, Tomaselli GF (2017) Neuromuscular disease: cardiac manifestations and sudden death risk. Card Electrophysiol Clin 9(4):731–747PubMedCrossRef Limpitikul W, Ong CS, Tomaselli GF (2017) Neuromuscular disease: cardiac manifestations and sudden death risk. Card Electrophysiol Clin 9(4):731–747PubMedCrossRef
9.
Zurück zum Zitat Sommerville RB, Vincenti MG, Winborn K, Casey A, Stitziel NO, Connolly AM, Mann DL (2017) Diagnosis and management of adult hereditary cardio-neuromuscular disorders: a model for the multidisciplinary care of complex genetic disorders. Trends Cardiovasc Med 27(1):51–58PubMedCrossRef Sommerville RB, Vincenti MG, Winborn K, Casey A, Stitziel NO, Connolly AM, Mann DL (2017) Diagnosis and management of adult hereditary cardio-neuromuscular disorders: a model for the multidisciplinary care of complex genetic disorders. Trends Cardiovasc Med 27(1):51–58PubMedCrossRef
10.
Zurück zum Zitat Rochitte CE, Liberato G, Silva MC (2019) Comprehensive assessment of cardiac involvement in muscular dystrophies by cardiac MR imaging. Magn Reson Imaging Clin N Am 27(3):521–531PubMedCrossRef Rochitte CE, Liberato G, Silva MC (2019) Comprehensive assessment of cardiac involvement in muscular dystrophies by cardiac MR imaging. Magn Reson Imaging Clin N Am 27(3):521–531PubMedCrossRef
11.
Zurück zum Zitat Power LC, O’Grady GL, Hornung TS, Jefferies C, Gusso S, Hofman PL (2018) Imaging the heart to detect cardiomyopathy in Duchenne muscular dystrophy: a review. Neuromuscul Disord 28(9):717–730PubMedCrossRef Power LC, O’Grady GL, Hornung TS, Jefferies C, Gusso S, Hofman PL (2018) Imaging the heart to detect cardiomyopathy in Duchenne muscular dystrophy: a review. Neuromuscul Disord 28(9):717–730PubMedCrossRef
12.
Zurück zum Zitat Poonja S, Power A, Mah JK, Fine NM, Greenway SC (2018) Current cardiac imaging approaches in Duchenne muscular dystrophy. J Clin Neuromuscul Dis 20(2):85–93PubMedCrossRef Poonja S, Power A, Mah JK, Fine NM, Greenway SC (2018) Current cardiac imaging approaches in Duchenne muscular dystrophy. J Clin Neuromuscul Dis 20(2):85–93PubMedCrossRef
13.
Zurück zum Zitat Corrado G, Lissoni A, Beretta S, Terenghi L, Tadeo G, Foglia-Manzillo G, Tagliagambe LM, Spata M, Santarone M (2002) Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 89(7):838–841PubMedCrossRef Corrado G, Lissoni A, Beretta S, Terenghi L, Tadeo G, Foglia-Manzillo G, Tagliagambe LM, Spata M, Santarone M (2002) Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 89(7):838–841PubMedCrossRef
14.
Zurück zum Zitat Jefferies JL, Eidem BW, Belmont JW, Craigen WJ, Ware SM, Fernbach SD, Neish SR, Smith EO, Towbin JA (2005) Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112(18):2799–2804PubMedCrossRef Jefferies JL, Eidem BW, Belmont JW, Craigen WJ, Ware SM, Fernbach SD, Neish SR, Smith EO, Towbin JA (2005) Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112(18):2799–2804PubMedCrossRef
15.
Zurück zum Zitat Pagourelias ED, Mirea O, Vovas G, Duchenne J, Michalski B, Van Cleemput J, Bogaert J, Vassilikos VP, Voigt JU (2019) Relation of regional myocardial structure and function in hypertrophic cardiomyopathy and amyloidosis: a combined two-dimensional speckle tracking and cardiovascular magnetic resonance analysis. Eur Heart J Cardiovasc Imaging 20(4):426–437PubMedCrossRef Pagourelias ED, Mirea O, Vovas G, Duchenne J, Michalski B, Van Cleemput J, Bogaert J, Vassilikos VP, Voigt JU (2019) Relation of regional myocardial structure and function in hypertrophic cardiomyopathy and amyloidosis: a combined two-dimensional speckle tracking and cardiovascular magnetic resonance analysis. Eur Heart J Cardiovasc Imaging 20(4):426–437PubMedCrossRef
16.
Zurück zum Zitat Yajima R, Kataoka A, Takahashi A, Uehara M, Saito M, Yamaguchi C, Lee K, Komuro I, Funabashi N (2012) Distinguishing focal fibrotic lesions and non-fibrotic lesions in hypertrophic cardiomyopathy by assessment of regional myocardial strain using two-dimensional speckle tracking echocardiography: comparison with multislice CT. Int J Cardiol 158(3):423–432PubMedCrossRef Yajima R, Kataoka A, Takahashi A, Uehara M, Saito M, Yamaguchi C, Lee K, Komuro I, Funabashi N (2012) Distinguishing focal fibrotic lesions and non-fibrotic lesions in hypertrophic cardiomyopathy by assessment of regional myocardial strain using two-dimensional speckle tracking echocardiography: comparison with multislice CT. Int J Cardiol 158(3):423–432PubMedCrossRef
17.
Zurück zum Zitat Mirea O, Duchenne J, Voigt JU (2016) Recent advances in echocardiography: strain and strain rate imaging. F1000Res 5: F1000 Faculty Rev-787. Published 2016 Apr 29 Mirea O, Duchenne J, Voigt JU (2016) Recent advances in echocardiography: strain and strain rate imaging. F1000Res 5: F1000 Faculty Rev-787. Published 2016 Apr 29
18.
Zurück zum Zitat Amedro P, Vincenti M, De La Villeon G, Lavastre K, Barrea C, Guillaumont S, Bredy C, Gamon L, Meli AC, Cazorla O, Fauconnier J, Meyer P, Rivier F, Adda J, Mura T, Lacampagne A (2019) Speckle-tracking echocardiography in children with Duchenne muscular dystrophy: a prospective multicenter controlled cross-sectional study. J Am Soc Echocardiogr 32(3):412–422PubMedCrossRef Amedro P, Vincenti M, De La Villeon G, Lavastre K, Barrea C, Guillaumont S, Bredy C, Gamon L, Meli AC, Cazorla O, Fauconnier J, Meyer P, Rivier F, Adda J, Mura T, Lacampagne A (2019) Speckle-tracking echocardiography in children with Duchenne muscular dystrophy: a prospective multicenter controlled cross-sectional study. J Am Soc Echocardiogr 32(3):412–422PubMedCrossRef
19.
Zurück zum Zitat Song G, Zhang J, Wang X, Zhang X, Sun F, Yu X (2020) Usefulness of speckle-tracking echocardiography for early detection in children with Duchenne muscular dystrophy: a meta-analysis and trial sequential analysis. Cardiovasc Ultrasound 18(1):26PubMedPubMedCentralCrossRef Song G, Zhang J, Wang X, Zhang X, Sun F, Yu X (2020) Usefulness of speckle-tracking echocardiography for early detection in children with Duchenne muscular dystrophy: a meta-analysis and trial sequential analysis. Cardiovasc Ultrasound 18(1):26PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Kamdar F, Garry DJ (2016) Dystrophin-deficient cardiomyopathy. J Am Coll Cardiol 67(21):2533–2546PubMedCrossRef Kamdar F, Garry DJ (2016) Dystrophin-deficient cardiomyopathy. J Am Coll Cardiol 67(21):2533–2546PubMedCrossRef
21.
Zurück zum Zitat Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, Hor K, Judge DP, Kinnett K, McNally EM, Raman S, Thompson WR, Wagner KR, Olson AK (2018) Cardiac management of the patient with Duchenne muscular dystrophy. Pediatrics 142(Suppl 2):S72–S81PubMedCrossRef Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, Hor K, Judge DP, Kinnett K, McNally EM, Raman S, Thompson WR, Wagner KR, Olson AK (2018) Cardiac management of the patient with Duchenne muscular dystrophy. Pediatrics 142(Suppl 2):S72–S81PubMedCrossRef
22.
Zurück zum Zitat Mavrogeni S, Markousis-Mavrogenis G, Papavasiliou A, Kolovou G (2015) Cardiac involvement in Duchenne and Becker muscular dystrophy. World J Cardiol 7(7):410–414PubMedPubMedCentralCrossRef Mavrogeni S, Markousis-Mavrogenis G, Papavasiliou A, Kolovou G (2015) Cardiac involvement in Duchenne and Becker muscular dystrophy. World J Cardiol 7(7):410–414PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Mavrogeni S, Papavasiliou A, Giannakopoulou K, Markousis-Mavrogenis G, Pons MR, Karanasios E, Nikas I, Papadopoulos G, Kolovou G, Chrousos GP (2017) Oedema-fibrosis in Duchenne muscular dystrophy: role of cardiovascular magnetic resonance imaging. Eur J Clin Invest 47(12). https://doi.org/10.1111/eci.12843 Mavrogeni S, Papavasiliou A, Giannakopoulou K, Markousis-Mavrogenis G, Pons MR, Karanasios E, Nikas I, Papadopoulos G, Kolovou G, Chrousos GP (2017) Oedema-fibrosis in Duchenne muscular dystrophy: role of cardiovascular magnetic resonance imaging. Eur J Clin Invest 47(12). https://​doi.​org/​10.​1111/​eci.​12843
24.
Zurück zum Zitat Brunklaus A, Parish E, Muntoni F, Scuplak S, Tucker SK, Fenton M, Hughes ML, Manzur AY (2015) The value of cardiac MRI versus echocardiography in the pre-operative assessment of patients with Duchenne muscular dystrophy. Eur J Paediatr Neurol 19(4):395–401PubMedCrossRef Brunklaus A, Parish E, Muntoni F, Scuplak S, Tucker SK, Fenton M, Hughes ML, Manzur AY (2015) The value of cardiac MRI versus echocardiography in the pre-operative assessment of patients with Duchenne muscular dystrophy. Eur J Paediatr Neurol 19(4):395–401PubMedCrossRef
25.
Zurück zum Zitat Nikolaidou C, Karamitsos TD (2020) Cardiac magnetic resonance in patients with muscular dystrophies: strengthening the data [published online ahead of print, 2020 Jun 10]. Eur J Prev Cardiol 2047487320932693 Nikolaidou C, Karamitsos TD (2020) Cardiac magnetic resonance in patients with muscular dystrophies: strengthening the data [published online ahead of print, 2020 Jun 10]. Eur J Prev Cardiol 2047487320932693
26.
Zurück zum Zitat Silva MC, Meira ZM, Gurgel Giannetti J, da Silva MM, Campos AF, Barbosa Mde M, Starling Filho GM, Ferreira Rde A, Zatz M, Rochitte CE (2007) Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 49(18):1874–1879PubMedCrossRef Silva MC, Meira ZM, Gurgel Giannetti J, da Silva MM, Campos AF, Barbosa Mde M, Starling Filho GM, Ferreira Rde A, Zatz M, Rochitte CE (2007) Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 49(18):1874–1879PubMedCrossRef
27.
Zurück zum Zitat Tandon A, Villa CR, Hor KN, Jefferies JL, Gao Z, Towbin JA, Wong BL, Mazur W, Fleck RJ, Sticka JJ, Benson DW, Taylor MD (2015) Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in Duchenne muscular dystrophy. J Am Heart Assoc 4(4):e001338PubMedPubMedCentralCrossRef Tandon A, Villa CR, Hor KN, Jefferies JL, Gao Z, Towbin JA, Wong BL, Mazur W, Fleck RJ, Sticka JJ, Benson DW, Taylor MD (2015) Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in Duchenne muscular dystrophy. J Am Heart Assoc 4(4):e001338PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Menon SC, Etheridge SP, Liesemer KN, Williams RV, Bardsley T, Heywood MC, Puchalski MD (2014) Predictive value of myocardial delayed enhancement in Duchenne muscular dystrophy. Pediatr Cardiol 35(7):1279–1285PubMedCrossRef Menon SC, Etheridge SP, Liesemer KN, Williams RV, Bardsley T, Heywood MC, Puchalski MD (2014) Predictive value of myocardial delayed enhancement in Duchenne muscular dystrophy. Pediatr Cardiol 35(7):1279–1285PubMedCrossRef
29.
Zurück zum Zitat Silva MC, Magalhães TA, Meira ZM, Rassi CH, Andrade AC, Gutierrez PS, Azevedo CF, Gurgel-Giannetti J, Vainzof M, Zatz M, Kalil-Filho R, Rochitte CE (2017) Myocardial fibrosis progression in Duchenne and Becker muscular dystrophy: a randomized clinical trial. JAMA Cardiol 2(2):190–199PubMedCrossRef Silva MC, Magalhães TA, Meira ZM, Rassi CH, Andrade AC, Gutierrez PS, Azevedo CF, Gurgel-Giannetti J, Vainzof M, Zatz M, Kalil-Filho R, Rochitte CE (2017) Myocardial fibrosis progression in Duchenne and Becker muscular dystrophy: a randomized clinical trial. JAMA Cardiol 2(2):190–199PubMedCrossRef
30.
Zurück zum Zitat Lang SM, Alsaied T, Khoury PR, Ryan TD, Taylor MD (2021) Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement. Int J Cardiovasc Imaging 37(2):635–642PubMedCrossRef Lang SM, Alsaied T, Khoury PR, Ryan TD, Taylor MD (2021) Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement. Int J Cardiovasc Imaging 37(2):635–642PubMedCrossRef
31.
Zurück zum Zitat Soslow JH, Damon BM, Saville BR, Lu Z, Burnette WB, Lawson MA, Parra DA, Sawyer DB, Markham LW (2015) Evaluation of post-contrast myocardial t1 in Duchenne muscular dystrophy using cardiac magnetic resonance imaging. Pediatr Cardiol 36(1):49–56PubMedCrossRef Soslow JH, Damon BM, Saville BR, Lu Z, Burnette WB, Lawson MA, Parra DA, Sawyer DB, Markham LW (2015) Evaluation of post-contrast myocardial t1 in Duchenne muscular dystrophy using cardiac magnetic resonance imaging. Pediatr Cardiol 36(1):49–56PubMedCrossRef
32.
Zurück zum Zitat Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C, DMD Care Considerations Working Group (2010) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9(1):77–93 Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C, DMD Care Considerations Working Group (2010) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9(1):77–93
33.
Zurück zum Zitat Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, Case LE, Clemens PR, Hadjiyannakis S, Pandya S, Street N, Tomezsko J, Wagner KR, Ward LM, Weber DR, DMD Care Considerations Working Group (2018) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management [published correction appears in lancet neurol 2018 Apr 4. Lancet Neurol 17(3):251–267 Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, Case LE, Clemens PR, Hadjiyannakis S, Pandya S, Street N, Tomezsko J, Wagner KR, Ward LM, Weber DR, DMD Care Considerations Working Group (2018) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management [published correction appears in lancet neurol 2018 Apr 4. Lancet Neurol 17(3):251–267
35.
Zurück zum Zitat Meyers TA, Townsend D (2019) Cardiac pathophysiology and the future of cardiac therapies in Duchenne muscular dystrophy. Int J Mol Sci 20(17):4098PubMedCentralCrossRef Meyers TA, Townsend D (2019) Cardiac pathophysiology and the future of cardiac therapies in Duchenne muscular dystrophy. Int J Mol Sci 20(17):4098PubMedCentralCrossRef
36.
Zurück zum Zitat McNally EM, Kaltman JR, Benson DW, Canter CE, Cripe LH, Duan D, Finder JD, Groh WJ, Hoffman EP, Judge DP, Kertesz N, Kinnett K, Kirsch R, Metzger JM, Pearson GD, Rafael-Fortney JA, Raman SV, Spurney CF, Targum SL, Wagner KR, Markham LW, Working Group of the National Heart, Lung, and Blood Institute (2015) Contemporary cardiac issues in Duchenne muscular dystrophy. working group of the national heart, lung, and blood institute in collaboration with parent project muscular dystrophy [published correction appears in circulation. 2015 Jun 23; 131(25): e539. Groh, William J [added]. Circulation 131(18):1590–1598 McNally EM, Kaltman JR, Benson DW, Canter CE, Cripe LH, Duan D, Finder JD, Groh WJ, Hoffman EP, Judge DP, Kertesz N, Kinnett K, Kirsch R, Metzger JM, Pearson GD, Rafael-Fortney JA, Raman SV, Spurney CF, Targum SL, Wagner KR, Markham LW, Working Group of the National Heart, Lung, and Blood Institute (2015) Contemporary cardiac issues in Duchenne muscular dystrophy. working group of the national heart, lung, and blood institute in collaboration with parent project muscular dystrophy [published correction appears in circulation. 2015 Jun 23; 131(25): e539. Groh, William J [added]. Circulation 131(18):1590–1598
38.
Zurück zum Zitat Siegel B, Olivieri L, Gordish-Dressman H, Spurney CF (2018) Myocardial strain using cardiac MR feature tracking and speckle tracking echocardiography in Duchenne muscular dystrophy patients. Pediatr Cardiol 39(3):478–483PubMedCrossRef Siegel B, Olivieri L, Gordish-Dressman H, Spurney CF (2018) Myocardial strain using cardiac MR feature tracking and speckle tracking echocardiography in Duchenne muscular dystrophy patients. Pediatr Cardiol 39(3):478–483PubMedCrossRef
39.
Zurück zum Zitat Nigro G, Comi LI, Politano L, Bain RJ (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26(3):271–277PubMedCrossRef Nigro G, Comi LI, Politano L, Bain RJ (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26(3):271–277PubMedCrossRef
40.
Zurück zum Zitat Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, Case LE, Cripe L, Hadjiyannakis S, Olson AK, Sheehan DW, Bolen J, Weber DR, Ward LM, DMD Care Considerations Working Group (2018) Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol 17(4):347–361 Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, Case LE, Cripe L, Hadjiyannakis S, Olson AK, Sheehan DW, Bolen J, Weber DR, Ward LM, DMD Care Considerations Working Group (2018) Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol 17(4):347–361
42.
Zurück zum Zitat Yilmaz A, Sechtem U (2012) Republished education in heart: cardiac involvement in muscular dystrophy: advances in diagnosis and therapy. Postgrad Med J 88(1039):290–299PubMedCrossRef Yilmaz A, Sechtem U (2012) Republished education in heart: cardiac involvement in muscular dystrophy: advances in diagnosis and therapy. Postgrad Med J 88(1039):290–299PubMedCrossRef
43.
Zurück zum Zitat Finsterer J, Stöllberger C (2000) Cardiac involvement in primary myopathies. Cardiology 94(1):1–11PubMedCrossRef Finsterer J, Stöllberger C (2000) Cardiac involvement in primary myopathies. Cardiology 94(1):1–11PubMedCrossRef
44.
Zurück zum Zitat Yilmaz A, Gdynia HJ, Baccouche H, Mahrholdt H, Meinhardt G, Basso C, Thiene G, Sperfeld AD, Ludolph AC, Sechtem U (2008) Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. J Cardiovasc Magn Reson 10(1):50PubMedPubMedCentralCrossRef Yilmaz A, Gdynia HJ, Baccouche H, Mahrholdt H, Meinhardt G, Basso C, Thiene G, Sperfeld AD, Ludolph AC, Sechtem U (2008) Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. J Cardiovasc Magn Reson 10(1):50PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Grigoratos C, Aimo A, Barison A, Castiglione V, Todiere G, Ricci G, Siciliano G, Emdin M (2020) Cardiac magnetic resonance in patients with muscular dystrophies [published online ahead of print, 2020 May 16]. Eur J Prev Cardiol 2047487320923052 Grigoratos C, Aimo A, Barison A, Castiglione V, Todiere G, Ricci G, Siciliano G, Emdin M (2020) Cardiac magnetic resonance in patients with muscular dystrophies [published online ahead of print, 2020 May 16]. Eur J Prev Cardiol 2047487320923052
46.
Zurück zum Zitat Florian A, Ludwig A, Rösch S, Yildiz H, Sechtem U, Yilmaz A (2014) Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging. Eur Heart J Cardiovasc Imaging 15(9):1004–1012PubMedCrossRef Florian A, Ludwig A, Rösch S, Yildiz H, Sechtem U, Yilmaz A (2014) Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging. Eur Heart J Cardiovasc Imaging 15(9):1004–1012PubMedCrossRef
47.
Zurück zum Zitat Marty B, Gilles R, Toussaint M, Béhin A, Stojkovic T, Eymard B, Carlier PG, Wahbi K (2019) Comprehensive evaluation of structural and functional myocardial impairments in Becker muscular dystrophy using quantitative cardiac magnetic resonance imaging. Eur Heart J Cardiovasc Imaging 20(8):906–915PubMedCrossRef Marty B, Gilles R, Toussaint M, Béhin A, Stojkovic T, Eymard B, Carlier PG, Wahbi K (2019) Comprehensive evaluation of structural and functional myocardial impairments in Becker muscular dystrophy using quantitative cardiac magnetic resonance imaging. Eur Heart J Cardiovasc Imaging 20(8):906–915PubMedCrossRef
48.
Zurück zum Zitat Bushby K, Muntoni F, Bourke JP (2003) 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th, June 2002 Naarden, the Netherlands. Neuromuscul Disord 13(2):166–172 Bushby K, Muntoni F, Bourke JP (2003) 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th, June 2002 Naarden, the Netherlands. Neuromuscul Disord 13(2):166–172
49.
Zurück zum Zitat Walton JN, Nattrass FJ (1954) On the classification, natural history and treatment of the myopathies. Brain 77(2):169–231PubMedCrossRef Walton JN, Nattrass FJ (1954) On the classification, natural history and treatment of the myopathies. Brain 77(2):169–231PubMedCrossRef
50.
Zurück zum Zitat Liewluck T, Milone M (2018) Untangling the complexity of limb-girdle muscular dystrophies. Muscle Nerve 58(2):167–177PubMedCrossRef Liewluck T, Milone M (2018) Untangling the complexity of limb-girdle muscular dystrophies. Muscle Nerve 58(2):167–177PubMedCrossRef
51.
Zurück zum Zitat Wicklund MP (2019) The limb-girdle muscular dystrophies continuum (minneap minn) 25(6):1599–1618 Wicklund MP (2019) The limb-girdle muscular dystrophies continuum (minneap minn) 25(6):1599–1618
52.
Zurück zum Zitat Angelini C, Giaretta L, Marozzo R (2018) An update on diagnostic options and considerations in limb-girdle dystrophies. Expert Rev Neurother 18(9):693–703PubMedCrossRef Angelini C, Giaretta L, Marozzo R (2018) An update on diagnostic options and considerations in limb-girdle dystrophies. Expert Rev Neurother 18(9):693–703PubMedCrossRef
53.
Zurück zum Zitat Angelini C (2020) LGMD. Identification, description and classification. Acta Myol 39(4):207–217 Angelini C (2020) LGMD. Identification, description and classification. Acta Myol 39(4):207–217
54.
Zurück zum Zitat Mah JK, Korngut L, Fiest KM, Dykeman J, Day LJ, Pringsheim T, Jette N (2016) A systematic review and meta-analysis on the epidemiology of the muscular dystrophies. Can J Neurol Sci 43(1):163–177PubMedCrossRef Mah JK, Korngut L, Fiest KM, Dykeman J, Day LJ, Pringsheim T, Jette N (2016) A systematic review and meta-analysis on the epidemiology of the muscular dystrophies. Can J Neurol Sci 43(1):163–177PubMedCrossRef
55.
Zurück zum Zitat Bushby KM (1995) Diagnostic criteria for the limb-girdle muscular dystrophies: report of the ENMC consortium on limb-girdle dystrophies. Neuromuscul Disord 5(1):71–74PubMedCrossRef Bushby KM (1995) Diagnostic criteria for the limb-girdle muscular dystrophies: report of the ENMC consortium on limb-girdle dystrophies. Neuromuscul Disord 5(1):71–74PubMedCrossRef
56.
Zurück zum Zitat Bushby KM, Beckmann JS (1995) The limb-girdle muscular dystrophies–proposal for a new nomenclature. Neuromuscul Disord 5(4):337–343PubMedCrossRef Bushby KM, Beckmann JS (1995) The limb-girdle muscular dystrophies–proposal for a new nomenclature. Neuromuscul Disord 5(4):337–343PubMedCrossRef
57.
Zurück zum Zitat Georganopoulou DG, Moisiadis VG, Malik FA, Mohajer A, Dashevsky TM, Wuu ST, Hu CK (2021) A journey with LGMD: from protein abnormalities to patient. Protein J 1–23 Georganopoulou DG, Moisiadis VG, Malik FA, Mohajer A, Dashevsky TM, Wuu ST, Hu CK (2021) A journey with LGMD: from protein abnormalities to patient. Protein J 1–23
58.
Zurück zum Zitat Straub V, Murphy A, Udd B, LGMD workshop study group, (2018) 229th ENMC international workshop: limb girdle muscular dystrophies - nomenclature and reformed classification Naarden, the Netherlands, 17–19 March 2017. Neuromuscul Disord 28(8):702–710PubMedCrossRef Straub V, Murphy A, Udd B, LGMD workshop study group, (2018) 229th ENMC international workshop: limb girdle muscular dystrophies - nomenclature and reformed classification Naarden, the Netherlands, 17–19 March 2017. Neuromuscul Disord 28(8):702–710PubMedCrossRef
59.
Zurück zum Zitat Verhaert D, Richards K, Rafael-Fortney JA, Raman SV (2011) Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations. Circ Cardiovasc Imaging 4(1):67–76PubMedPubMedCentralCrossRef Verhaert D, Richards K, Rafael-Fortney JA, Raman SV (2011) Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations. Circ Cardiovasc Imaging 4(1):67–76PubMedPubMedCentralCrossRef
60.
Zurück zum Zitat Gaul C, Deschauer M, Tempelmann C, Vielhaber S, Klein HU, Heinze HJ, Zierz S, Grothues F (2006) Cardiac involvement in limb-girdle muscular dystrophy 2I : conventional cardiac diagnostic and cardiovascular magnetic resonance. J Neurol 253(10):1317–1322PubMedCrossRef Gaul C, Deschauer M, Tempelmann C, Vielhaber S, Klein HU, Heinze HJ, Zierz S, Grothues F (2006) Cardiac involvement in limb-girdle muscular dystrophy 2I : conventional cardiac diagnostic and cardiovascular magnetic resonance. J Neurol 253(10):1317–1322PubMedCrossRef
61.
Zurück zum Zitat Calvo F, Teijeira S, Fernandez JM, Teijeiro A, Fernandez-Hojas R, Fernandez-Lopez XA, Martin E, Navarro C (2000) Evaluation of heart involvement in gamma-sarcoglycanopathy (LGMD2C). A study of ten patients. Neuromuscul Disord 10(8):560–566 Calvo F, Teijeira S, Fernandez JM, Teijeiro A, Fernandez-Hojas R, Fernandez-Lopez XA, Martin E, Navarro C (2000) Evaluation of heart involvement in gamma-sarcoglycanopathy (LGMD2C). A study of ten patients. Neuromuscul Disord 10(8):560–566
62.
Zurück zum Zitat Wahbi K, Meune C, el Hamouda H, Stojkovic T, Laforêt P, Bécane HM, Eymard B, Duboc D (2008) Cardiac assessment of limb-girdle muscular dystrophy 2I patients: an echography, Holter ECG and magnetic resonance imaging study. Neuromuscul Disord 18(8):650–655PubMedCrossRef Wahbi K, Meune C, el Hamouda H, Stojkovic T, Laforêt P, Bécane HM, Eymard B, Duboc D (2008) Cardiac assessment of limb-girdle muscular dystrophy 2I patients: an echography, Holter ECG and magnetic resonance imaging study. Neuromuscul Disord 18(8):650–655PubMedCrossRef
63.
Zurück zum Zitat Heller SA, Shih R, Kalra R, Kang PB (2020) Emery-dreifuss muscular dystrophy. Muscle Nerve 61(4):436–448PubMedCrossRef Heller SA, Shih R, Kalra R, Kang PB (2020) Emery-dreifuss muscular dystrophy. Muscle Nerve 61(4):436–448PubMedCrossRef
64.
Zurück zum Zitat Wang S, Peng D (2019) Cardiac involvement in Emery-dreifuss muscular dystrophy and related management strategies. Int Heart J 60(1):12–18PubMedCrossRef Wang S, Peng D (2019) Cardiac involvement in Emery-dreifuss muscular dystrophy and related management strategies. Int Heart J 60(1):12–18PubMedCrossRef
65.
Zurück zum Zitat Smith GC, Kinali M, Prasad SK et al (2006) Primary myocardial dysfunction in autosomal dominant EDMD. A tissue doppler and cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 8(5):723–730 Smith GC, Kinali M, Prasad SK et al (2006) Primary myocardial dysfunction in autosomal dominant EDMD. A tissue doppler and cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 8(5):723–730
66.
Zurück zum Zitat Marchel M, Madej-Pilarczyk A, Tymińska A, Steckiewicz R, Kochanowski J, Wysińska J, Ostrowska E, Balsam P, Grabowski M, Opolski G (2021) Echocardiographic features of cardiomyopathy in Emery-dreifuss muscular dystrophy. Cardiol Res Pract 2021:8812044PubMedPubMedCentralCrossRef Marchel M, Madej-Pilarczyk A, Tymińska A, Steckiewicz R, Kochanowski J, Wysińska J, Ostrowska E, Balsam P, Grabowski M, Opolski G (2021) Echocardiographic features of cardiomyopathy in Emery-dreifuss muscular dystrophy. Cardiol Res Pract 2021:8812044PubMedPubMedCentralCrossRef
67.
Zurück zum Zitat Butt K, Ambati S (2020) Atrial arrhythmias in Emery-dreifuss muscular dystrophy: approach to successful ablation. Heart Rhythm Case Rep 6(6):318–321 Butt K, Ambati S (2020) Atrial arrhythmias in Emery-dreifuss muscular dystrophy: approach to successful ablation. Heart Rhythm Case Rep 6(6):318–321
68.
Zurück zum Zitat Draminska A, Kuch-Wocial A, Szulc M, Zwolinska A, Styczynski G, Kostrubiec M, Hausmanowa-Petrusewicz I, Pruszczyk P (2005) Echocardiographic assessment of left ventricular morphology and function in patients with Emery-dreifuss muscular dystrophy. Int J Cardiol 102(2):207–210PubMedCrossRef Draminska A, Kuch-Wocial A, Szulc M, Zwolinska A, Styczynski G, Kostrubiec M, Hausmanowa-Petrusewicz I, Pruszczyk P (2005) Echocardiographic assessment of left ventricular morphology and function in patients with Emery-dreifuss muscular dystrophy. Int J Cardiol 102(2):207–210PubMedCrossRef
69.
Zurück zum Zitat Turkbey EB, Gai N, Lima JA, van der Geest RJ, Wagner KR, Tomaselli GF, Bluemke DA, Nazarian S (2012) Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging. Heart Rhythm 9(10):1691–1697PubMedPubMedCentralCrossRef Turkbey EB, Gai N, Lima JA, van der Geest RJ, Wagner KR, Tomaselli GF, Bluemke DA, Nazarian S (2012) Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging. Heart Rhythm 9(10):1691–1697PubMedPubMedCentralCrossRef
70.
71.
Zurück zum Zitat Lau JK, Sy RW, Corbett A, Kritharides L (2015) Myotonic dystrophy and the heart: a systematic review of evaluation and management. Int J Cardiol 184:600–608PubMedCrossRef Lau JK, Sy RW, Corbett A, Kritharides L (2015) Myotonic dystrophy and the heart: a systematic review of evaluation and management. Int J Cardiol 184:600–608PubMedCrossRef
72.
Zurück zum Zitat Johnson NE, Heatwole CR (2012) Myotonic dystrophy: from bench to bedside. Semin Neurol 32(3):246–254PubMedCrossRef Johnson NE, Heatwole CR (2012) Myotonic dystrophy: from bench to bedside. Semin Neurol 32(3):246–254PubMedCrossRef
73.
Zurück zum Zitat De Ambroggi L, Raisaro A, Marchianó V, Radice S, Meola G (1995) Cardiac involvement in patients with myotonic dystrophy: characteristic features of magnetic resonance imaging. Eur Heart J 16(7):1007–1010PubMedCrossRef De Ambroggi L, Raisaro A, Marchianó V, Radice S, Meola G (1995) Cardiac involvement in patients with myotonic dystrophy: characteristic features of magnetic resonance imaging. Eur Heart J 16(7):1007–1010PubMedCrossRef
74.
Zurück zum Zitat Samanta R, Pouliopoulos J, Thiagalingam A, Kovoor P (2016) Role of adipose tissue in the pathogenesis of cardiac arrhythmias. Heart Rhythm 13(1):311–320PubMedCrossRef Samanta R, Pouliopoulos J, Thiagalingam A, Kovoor P (2016) Role of adipose tissue in the pathogenesis of cardiac arrhythmias. Heart Rhythm 13(1):311–320PubMedCrossRef
75.
Zurück zum Zitat Chmielewski L, Bietenbeck M, Patrascu A, Rösch S, Sechtem U, Yilmaz A, Florian AR (2019) Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1. Clin Res Cardiol 108(8):857–867PubMedCrossRef Chmielewski L, Bietenbeck M, Patrascu A, Rösch S, Sechtem U, Yilmaz A, Florian AR (2019) Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1. Clin Res Cardiol 108(8):857–867PubMedCrossRef
76.
Zurück zum Zitat McNally EM, Mann DL, Pinto Y, Bhakta D, Tomaselli G, Nazarian S, Groh WJ, Tamura T, Duboc D, Itoh H, Hellerstein L, Mammen PPA (2020) Clinical care recommendations for cardiologists treating adults with myotonic dystrophy. J Am Heart Assoc 9(4):e014006PubMedPubMedCentralCrossRef McNally EM, Mann DL, Pinto Y, Bhakta D, Tomaselli G, Nazarian S, Groh WJ, Tamura T, Duboc D, Itoh H, Hellerstein L, Mammen PPA (2020) Clinical care recommendations for cardiologists treating adults with myotonic dystrophy. J Am Heart Assoc 9(4):e014006PubMedPubMedCentralCrossRef
77.
Zurück zum Zitat Paunic T, Peric S, Cvitan E, Raspopovic S, Peric M, Mandic Stojmenovic G, Rakocevic Stojanovic V (2017) Routine echocardiography in patients with myotonic dystrophy type 1. J Chin Med Assoc 80(7):408–412PubMedCrossRef Paunic T, Peric S, Cvitan E, Raspopovic S, Peric M, Mandic Stojmenovic G, Rakocevic Stojanovic V (2017) Routine echocardiography in patients with myotonic dystrophy type 1. J Chin Med Assoc 80(7):408–412PubMedCrossRef
78.
Zurück zum Zitat Garcia R, Labarre Q, Degand B, Ingrand P, Le Gal F, Bonnet B, Delaubier A, Guillou C, Gellen B, Coisne D, Bouleti C, Christiaens L (2017) Apical left ventricular myocardial dysfunction is an early feature of cardiac involvement in myotonic dystrophy type 1. Echocardiography 34(2):184–190PubMedCrossRef Garcia R, Labarre Q, Degand B, Ingrand P, Le Gal F, Bonnet B, Delaubier A, Guillou C, Gellen B, Coisne D, Bouleti C, Christiaens L (2017) Apical left ventricular myocardial dysfunction is an early feature of cardiac involvement in myotonic dystrophy type 1. Echocardiography 34(2):184–190PubMedCrossRef
79.
Zurück zum Zitat Hermans MC, Faber CG, Bekkers SC, de Die-Smulders CE, Gerrits MM, Merkies IS, Snoep G, Pinto YM, Schalla S (2012) Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 14(1):48PubMedPubMedCentralCrossRef Hermans MC, Faber CG, Bekkers SC, de Die-Smulders CE, Gerrits MM, Merkies IS, Snoep G, Pinto YM, Schalla S (2012) Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 14(1):48PubMedPubMedCentralCrossRef
80.
Zurück zum Zitat Petri H, Ahtarovski KA, Vejlstrup N, Vissing J, Witting N, Køber L, Bundgaard H (2014) Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 16(1):59PubMedPubMedCentralCrossRef Petri H, Ahtarovski KA, Vejlstrup N, Vissing J, Witting N, Køber L, Bundgaard H (2014) Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 16(1):59PubMedPubMedCentralCrossRef
81.
Zurück zum Zitat Dutka DP, Donnelly JE, Nihoyannopoulos P, Oakley CM, Nunez DJ (1999) Marked variation in the cardiomyopathy associated with Friedreich’s ataxia. Heart 81(2):141–147PubMedPubMedCentralCrossRef Dutka DP, Donnelly JE, Nihoyannopoulos P, Oakley CM, Nunez DJ (1999) Marked variation in the cardiomyopathy associated with Friedreich’s ataxia. Heart 81(2):141–147PubMedPubMedCentralCrossRef
82.
Zurück zum Zitat Tanaka H (2021) Efficacy of echocardiography for differential diagnosis of left ventricular hypertrophy: special focus on speckle-tracking longitudinal strain. J Echocardiogr 19(2):71–79PubMedPubMedCentralCrossRef Tanaka H (2021) Efficacy of echocardiography for differential diagnosis of left ventricular hypertrophy: special focus on speckle-tracking longitudinal strain. J Echocardiogr 19(2):71–79PubMedPubMedCentralCrossRef
83.
Zurück zum Zitat Lynch DR, Regner SR, Schadt KA, Friedman LS, Lin KY, St John Sutton MG (2012) Management and therapy for cardiomyopathy in Friedreich’s ataxia. Expert Rev Cardiovasc Ther 10(6):767–777PubMedCrossRef Lynch DR, Regner SR, Schadt KA, Friedman LS, Lin KY, St John Sutton MG (2012) Management and therapy for cardiomyopathy in Friedreich’s ataxia. Expert Rev Cardiovasc Ther 10(6):767–777PubMedCrossRef
84.
Zurück zum Zitat Weidemann F, Störk S, Liu D, Hu K, Herrmann S, Ertl G, Niemann M (2013) Cardiomyopathy of Friedreich ataxia. J Neurochem 126(Suppl 1):88–93PubMedCrossRef Weidemann F, Störk S, Liu D, Hu K, Herrmann S, Ertl G, Niemann M (2013) Cardiomyopathy of Friedreich ataxia. J Neurochem 126(Suppl 1):88–93PubMedCrossRef
85.
Zurück zum Zitat Dedobbeleer C, Rai M, Donal E, Pandolfo M, Unger P (2012) Normal left ventricular ejection fraction and mass but subclinical myocardial dysfunction in patients with Friedreich’s ataxia. Eur Heart J Cardiovasc Imaging 13(4):346–352PubMedCrossRef Dedobbeleer C, Rai M, Donal E, Pandolfo M, Unger P (2012) Normal left ventricular ejection fraction and mass but subclinical myocardial dysfunction in patients with Friedreich’s ataxia. Eur Heart J Cardiovasc Imaging 13(4):346–352PubMedCrossRef
86.
Zurück zum Zitat Legrand L, Diallo A, Monin ML, Ewenczyk C, Charles P, Isnard R, Vicaut E, Montalescot G, Durr A, Pousset F (2020) Predictors of left ventricular dysfunction in Friedreich’s ataxia in a 16-year observational study. Am J Cardiovasc Drugs 20(2):209–216PubMedCrossRef Legrand L, Diallo A, Monin ML, Ewenczyk C, Charles P, Isnard R, Vicaut E, Montalescot G, Durr A, Pousset F (2020) Predictors of left ventricular dysfunction in Friedreich’s ataxia in a 16-year observational study. Am J Cardiovasc Drugs 20(2):209–216PubMedCrossRef
87.
Zurück zum Zitat Weidemann F, Rummey C, Bijnens B, Störk S, Jasaityte R, Dhooge J, Baltabaeva A, Sutherland G, Schulz JB, Meier T, Mitochondrial Protection with Idebenone in Cardiac or Neurological Outcome (MICONOS) study group (2012) The heart in Friedreich ataxia: definition of cardiomyopathy, disease severity, and correlation with neurological symptoms. Circulation 125(13):1626–1634 Weidemann F, Rummey C, Bijnens B, Störk S, Jasaityte R, Dhooge J, Baltabaeva A, Sutherland G, Schulz JB, Meier T, Mitochondrial Protection with Idebenone in Cardiac or Neurological Outcome (MICONOS) study group (2012) The heart in Friedreich ataxia: definition of cardiomyopathy, disease severity, and correlation with neurological symptoms. Circulation 125(13):1626–1634
88.
Zurück zum Zitat Takazaki KAG, Quinaglia T, Venancio TD, Martinez ARM, Shah RV, Neilan TG, Jerosch-Herold M, Coelho-Filho OR, França MC Jr (2021) Pre-clinical left ventricular myocardial remodeling in patients with Friedreich’s ataxia: a cardiac MRI study. PLoS ONE 16(3):e0246633PubMedPubMedCentralCrossRef Takazaki KAG, Quinaglia T, Venancio TD, Martinez ARM, Shah RV, Neilan TG, Jerosch-Herold M, Coelho-Filho OR, França MC Jr (2021) Pre-clinical left ventricular myocardial remodeling in patients with Friedreich’s ataxia: a cardiac MRI study. PLoS ONE 16(3):e0246633PubMedPubMedCentralCrossRef
Metadaten
Titel
Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging
verfasst von
Georgios M. Alexandridis
Efstathios D. Pagourelias
Nikolaos Fragakis
Maria Kyriazi
Efthymia Vargiami
Dimitrios Zafeiriou
Vassilios P. Vassilikos
Publikationsdatum
20.07.2022
Verlag
Springer US
Erschienen in
Heart Failure Reviews / Ausgabe 6/2022
Print ISSN: 1382-4147
Elektronische ISSN: 1573-7322
DOI
https://doi.org/10.1007/s10741-022-10260-8

Weitere Artikel der Ausgabe 6/2022

Heart Failure Reviews 6/2022 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.